1. Home
  2. CYCN vs RVYL Comparison

CYCN vs RVYL Comparison

Compare CYCN & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
    SELLHOLDBUYas of 2 hours ago
  • RVYL
    SELLHOLDBUYas of 2 hours ago
  • Stock Information
  • Founded
  • CYCN 2018
  • RVYL 2007
  • Country
  • CYCN United States
  • RVYL United States
  • Employees
  • CYCN N/A
  • RVYL N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • RVYL Professional Services
  • Sector
  • CYCN Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • CYCN Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • CYCN 7.5M
  • RVYL 8.3M
  • IPO Year
  • CYCN N/A
  • RVYL N/A
  • Fundamental
  • Price
  • CYCN $2.60
  • RVYL $0.95
  • Analyst Decision
  • CYCN
  • RVYL Hold
  • Analyst Count
  • CYCN 0
  • RVYL 1
  • Target Price
  • CYCN N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • CYCN 31.9K
  • RVYL 43.2K
  • Earning Date
  • CYCN 03-04-2025
  • RVYL 05-13-2025
  • Dividend Yield
  • CYCN N/A
  • RVYL N/A
  • EPS Growth
  • CYCN N/A
  • RVYL N/A
  • EPS
  • CYCN N/A
  • RVYL N/A
  • Revenue
  • CYCN $2,000,000.00
  • RVYL $55,998,000.00
  • Revenue This Year
  • CYCN N/A
  • RVYL $52.59
  • Revenue Next Year
  • CYCN N/A
  • RVYL N/A
  • P/E Ratio
  • CYCN N/A
  • RVYL N/A
  • Revenue Growth
  • CYCN N/A
  • RVYL N/A
  • 52 Week Low
  • CYCN $1.27
  • RVYL $0.69
  • 52 Week High
  • CYCN $9.47
  • RVYL $2.76
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 47.88
  • RVYL 42.95
  • Support Level
  • CYCN $2.44
  • RVYL $0.73
  • Resistance Level
  • CYCN $2.68
  • RVYL $1.18
  • Average True Range (ATR)
  • CYCN 0.20
  • RVYL 0.11
  • MACD
  • CYCN 0.02
  • RVYL -0.01
  • Stochastic Oscillator
  • CYCN 39.83
  • RVYL 39.04

Stock Price Comparison Chart: CYCN vs RVYL

CYCN
RVYL
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April020406080100120140160CYCN VS RVYL

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use